• Global
    • US
    • Global
    • 中文
    • 繁体

Home

  • BeiGene

Main navigation

  • About
    • Our Story
    • Leadership Team
      • Meet More of Our Team
    • Focus on Quality
    • Who We Are
    • Ethics
  • Science & Pipeline
    • Research & Development
    • Manufacturing
    • Pipeline
      • Zanubrutinib
      • Tislelizumab
      • Pamiparib
      • Lifirafenib
      • Preclinical Candidates
  • Partnering
    • Partnering with BeiGene
    • Doing Business in China
  • BeiGene
  • Patients
    • Clinical Trials
    • Access to Investigational Medicines
  • Careers
    • Culture & Benefits
    • Job Opportunities
  • Investors
    • NASDAQ Investors
    • HKEX Investors
      • Investors Overview
      • Corporate Governance
      • Listing Documents
      • Stock Information
        • Stock Chart
      • Analyst Coverage
      • Financial Report
      • Investor Presentation
      • Investor Video
      • Email Alerts
      • HKEX Announcements
      • Circular
      • Press Release
      • Event Calendar
        • BeiGene to Host Investor Conference Call and Webcast to Discuss the Company’s Early Development Pipeline and Research
        • BeiGene at Goldman Sachs 41st Annual Global Healthcare Conference
        • BeiGene to Discuss Clinical Study Results Presented at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program
        • BeiGene at Cowen and Company's 40th Annual Health Care Conference
        • BeiGene to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
        • BeiGene at the Piper Sandler 32nd Annual Virtual Healthcare Conference
        • BeiGene 2020 China National Reimbursement Drug List (NRDL) Results Conference Call
        • BeiGene to Present at the J.P. Morgan 39th Annual Healthcare Conference
      • IR Contact
  • Media
  • Contact

HKEX Investor Relations
  • Investors Overview
  • Corporate Governance
  • Listing Documents
  • Stock Information
    • Stock Chart
  • Analyst Coverage
  • Financial Report
  • Investor Presentation
  • Investor Video
  • Email Alerts
  • HKEX Announcements
  • Circular
  • Press Release
  • Event Calendar
  • IR Contact
BeiGene at Cowen and Company's 40th Annual Health Care Conference
Tuesday, March 3, 2020 at 11:20 a.m. ET (Wednesday, March 4 at 11:20 a.m. Beijing/HongKong)
Click here for webcast
BeiGene
© 2018 BeiGene. All Rights Reserved.
Developed by Euroland IR
  • About
  • Science & Pipeline
  • Partnering
  • Patients
  • Careers
  • Investors
  • Media
  • Contact
  • SiteMap
  • Terms of Use
  • Privacy Policy
© 2018 BeiGene. All Rights Reserved.
Developed by Euroland IR